Stock 0LSZ WALGREENS BOOTS ALLIANCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Walgreens Boots Alliance, Inc. London S.E.

Equities

0LSZ

US9314271084

Market Closed - London S.E.
Other stock markets
 07:36:55 01/07/2024 pm IST 		5-day change 1st Jan Change
12 USD -18.09% Intraday chart for Walgreens Boots Alliance, Inc. +0.17% -53.81%
03/07 Top Decliners MT
03/07 UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating MT

Strengths

  • The stock, which is currently worth 2024 to 0.12 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • This company will be of major interest to investors in search of a high dividend stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-53.81% 9.58B -
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-45.52% 8.84B
B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-24.76% 6.63B
B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-5.95% 6.17B
C+
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+91.60% 5B
C
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-3.50% 4.58B
D-
CLICKS GROUP LIMITED Stock Clicks Group Limited
+1.56% 4.4B
B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-27.53% 3.96B
C
REDCARE PHARMACY NV Stock Redcare Pharmacy NV
+2.28% 2.85B
B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-20.90% 2.53B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. WBA Stock
  4. 0LSZ Stock
  5. Ratings Walgreens Boots Alliance, Inc.